Cancer charity founder and cancer genetics pioneer honoured at ICR graduation ceremony 22 Mar 2024 The ICR honoured the founder of CRIS Cancer Foundation, Lola Manterola, and cancer genetics researcher, Professor Sir Bruce Ponder, with honorary degrees at their annual graduation and awards ceremony. Find out more Show/Hide
ICR welcomes appointment of Aviva and Socius for new life-sciences development at The London Cancer Hub 22 Jan 2024 The Institute of Cancer Research has welcomed the appointment of a new partnership to deliver a major redevelopment project at The London Cancer Hub in Sutton. Find out more Show/Hide
ICR welcomes FDA approval of first-in-class breast cancer drug 17 Nov 2023 The ICR strongly welcomes the news that a new targeted drug, capivasertib, has been approved by the US FDA for treating the most common type of advanced breast cancer. The drug was discovered by pharmaceutical company AstraZeneca following a programme of drug discovery research at the ICR in collaboration with Astex Pharmaceuticals. Find out more Show/Hide